Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study
Abstract Introduction Moderate to severe ocular surface disease (OSD) can substantially impair quality of life in patients with lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy. Although multiple studies have reported cases of OSD associated with EG...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-07-01
|
| Series: | Ophthalmology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40123-025-01200-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|